IP Library Granted Patent US 9,101,565
Granted Patent B2
US 9,101,565 · App. 13/129,664 · Granted Aug 11, 2015

Dissolution stability of calcium carbonate tablets

Inventors: Peder Mohr Olsen (Kirke Hyllinge, DK); Poul Egon Bertelsen (Roskilde, DK); Thomas Thisted (Kibaek, DK); Henrik Ravn Aage (Copenhagen N, DK)
Assignee: TAKEDA NYCOMED AS
A61K33/06A61K9/2018A61K9/2072A61K9/2095
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,101,565
App. No.
13/129,664
Granted
Aug 11, 2015
Kind
B2
Abstract

The present invention relates to a method for the preparation of a tablet comprising at least 50% w/w of calcium carbonate, the method comprising i) providing a particulate composition comprising a) calcium carbonate, b) a binding sugar alcohol selected from sorbitol or isomalt, or combinations thereof, c) a non-binding sugar alcohol selected from mannitol, maltitol or xylitol, or combinations thereof, and ii) compressing said composition using a tabletting machine equipped with at least one pair of punches and dies, wherein the pair of punches and die before filling the die with said particulate composition is sprayed with a composition comprising a lubricant selected from magnesium stearate, calcium stearate or stearic acid or combinations thereof.

Claims (20)

1. A calcium carbonate tablet containing:

70-75% w/w of calcium carbonate;

2-10% w/w of one or more binding sugar alcohols selected from sorbitol, isomalt and combination thereof;

4-25% w/w of one or more non-binding sugar alcohols selected from mannitol, maltitol, xylitol and combinations thereof;

2-10% w/w of one or more pharmaceutically acceptable excipients, wherein said excipients are not lubricants;

0-2% w/w of one or more flavours, or artificial sweeteners; and

0.3-0.4% w/w of internally applied magnesium stearate, calcium stearate or stearic acid, wherein the magnesium stearate, calcium stearate or stearic acid is admixed with the calcium carbonate, the one or more binding sugar alcohols, the one or more non-binding sugar alcohols and the one or more pharmaceutically acceptable excipients;

with the proviso that the total amount of the calcium carbonate tablet corresponds to 100% w/w.

2. A method for the preparation of a calcium carbonate tablet containing:

70-75% w/w of calcium carbonate;

2-10% w/w of one or more binding sugar alcohols selected from sorbitol, isomalt and combination thereof;

4-25% w/w of one or more non-binding sugar alcohols selected from mannitol, maltitol, xylitol and combinations thereof;

2-10% w/w of one or more pharmaceutically acceptable excipients, wherein said excipients are not lubricants;

0-2% w/w of one or more flavours, or artificial sweeteners; and

0.3-0.4% w/w of internally applied magnesium stearate, calcium stearate or stearic acid, wherein the magnesium stearate, calcium stearate or stearic acid is admixed with the calcium carbonate, the one or more binding sugar alcohols, the one or more non-binding sugar alcohols and the one or more pharmaceutically acceptable excipients;

with the proviso that the total amount of the calcium carbonate tablet corresponds to 100% w/w; the method comprising:

(i) roller compacting a)the calcium carbonate, b) the one or more binding sugar alcohols selected from sorbitol, isomalt and combinations thereof and c) the non-binding sugar alcohol selected from mannitol, maltitol or xylitol to obtain a roller compacted granulate;

(ii) admixing the magnesium stearate, calcium stearate or stearic acid in a mixer; and

(iii) compressing the resulting composition using a tabletting machine.

3. A calcium carbonate tablet obtainable by a method as claimed in claim 2 .

Assignments (4)
CHANGE OF NAME Recorded Nov 19, 2015
From: TAKEDA NYCOMED AS
To: TAKEDA AS
Reel/Frame 037147/0646 →
CHANGE OF NAME Recorded Aug 23, 2013
From: NYCOMED PHARMA AS
To: TAKEDA NYCOMED AS
Reel/Frame 031077/0058 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2011
From: OLSEN, PEDER MOHR; BERTELSEN, POUL EGON; THISTED, THOMAS; AAGE, HENRIK RAVN
To: NYCOMED DANMARK APS
Reel/Frame 026691/0858 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2011
From: NYCOMED DANMARK APS
To: NYCOMED PHARMA AS
Reel/Frame 026691/0874 →
Priority Claims (1)
EP 08169264 · Nov 17, 2008 · regional
Continuity (1)
Related Publication 20110287098A1 · Nov 24, 2011